Sense Biodetection
Latest round
- Series B
Last raised
- Nov 2021
Total raised
- $79M
Investors
- 4
About Sense Biodetection
Sense Biodetection Limited, founded in 2014 in Abingdon, UK, is focused on developing innovative diagnostic tools. The company was acquired by Sherlock Biosciences, Inc. in February 2023, enhancing their go-to-market strategy with new manufacturing capabilities. Harry Lamble is the CEO of Sense Biodetection.Sense Biodetection, now part of OraSure Technologies, focuses on biotechnology solutions, specifically advanced diagnostic tools that facilitate efficient disease detection. Their products are designed for healthcare providers, laboratories, and clinical environments, ensuring rapid testing capabilities aimed at improving health outcomes.Following the acquisition by Sherlock Biosciences, Inc. in February 2023, Sense Biodetection plans to leverage its rapid molecular test platform to enhance product offerings. The integration will focus on expanding manufacturing capabilities and entering new markets by deploying innovative products.
Who invested in Sense Biodetection
4 investors across 4 rounds
See all investors in Sense Biodetection
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sense Biodetection
Who invested in Sense Biodetection?
Sense Biodetection has 4 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sense Biodetection raised?
Sense Biodetection has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Sense Biodetection last raise money?
Sense Biodetection's most recent round on record is a Series B, in Nov 2021.
What does Sense Biodetection do?
Sense Biodetection Limited, founded in 2014 in Abingdon, UK, is focused on developing innovative diagnostic tools.
Where is Sense Biodetection headquartered?
Sense Biodetection is headquartered in Abingdon, UK.
Which VCs invest in companies like Sense Biodetection?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at Sense Biodetection's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Sense Biodetection? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.